InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,009.11
(
-1.23%
)
US TECH 100
16,807.60
(
-1.48%
)
Dow Jones
37,868.14
(
-1.54%
)
Brent Oil
86.60
(
-0.72%
)
Bitcoin
63,594.11
(
-1.07%
)
Post# of 423548
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Williams4076

Send PM Follow Ignore
Followers 0
Posts 994
Boards Moderated 0
Alias Born 06/03/2015

Williams4076

Re: Williams4076 post# 54814

Tuesday, 07/28/2015 9:15:10 PM

Tuesday, July 28, 2015 9:15:10 PM

Post# of 423548
It's clear the intent of this letter was to support FDA's decision for not granting Vascepa exclusivity, it was received on July 3 2014. FDA made Amarin exclusivity mistake on Feb 21 2014.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Start posting your company's news
Only $200 per official company press release!